# Immunovant, Inc.: Form SCHEDULE 13D/A, filed Dec 12, 2025

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: SCHEDULE 13D/A
- Filed: 2025-12-12
- Accepted by EDGAR: Dec 12, 2025, 17:20 ET
- Period: not reported
- Accession: 0001140361-25-045411
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000114036125045411/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000114036125045411/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000114036125045411/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Dec 12, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-045411. Last ingested by Listed: Nov 13, 2026, 16:26 ET. No prices; not investment advice.
